Rafferty Asset Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
Rafferty Asset Management's ALT Position: Q2 2026 in Review
Rafferty Asset Management reduced its Altimmune (ALT) stake by 2.7% in Q2 2026, selling an estimated $18.6K and leaving 225,060 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #845.
Rafferty Asset Management first reported a position in ALT in Q1 2021 and has held it in 17 quarters since. The position peaked at $9.85M in Q4 2022. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Rafferty Asset Management held 225,060 shares of Altimmune worth $684K as of Q2 2026.
- Rafferty Asset Management sold 6,211 Altimmune shares in Q2 2026, an estimated $18.6K.
- Altimmune made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #845 holding.
- Rafferty Asset Management first reported a position in Altimmune in Q1 2021 and has held it in 17 quarters since.
- Rafferty Asset Management's Altimmune position peaked at $9.85M in Q4 2022.
- 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.